Sian Farrell Email

CEO, Co-Founder . StimOxyGen

Current Roles

Employees:
3
Revenue:
$153k
About
StimOxyGen is a proprietary and world-leading innovative approach to address the global challenge of tumour hypoxia. \n\nHypoxia, or lack of oxygen, is a common characteristic of solid tumours that contributes to the failure of many types of cancer treatment, particularly radiotherapy which relies on oxygen for maximum efficacy. \n\nWe can solve this longstanding major unmet clinical need by fueling tumours with oxygen to maximise therapeutic effects of radiotherapy.
StimOxyGen Address

Coleraine, null
UK
StimOxyGen Email